#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	2424	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2622	204.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1659	1659	C	249	C	206	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	2424	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2622	204.4	0	HET	.	.	.	C542T,A	.	542	542	C	1017	1017	C	281	C,T,A	173,59,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4472	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3962	246.7	0	.	n	.	0	T695C	SNP	695	695	T	1342	1342	C	247	C,A	204,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4472	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3962	246.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1984	1984	A	273	A	229	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4472	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3962	246.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2618	2618	C	313	C	267	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4472	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3962	246.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2692	2692	A	312	A	262	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4472	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3962	246.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	3244	3244	C	321	C,T	261,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	596	folP	855	855	100.0	folP.l15.c4.ctg.1	2077	64.6	1	SNP	p	R229S	1	.	.	685	687	AGC	1355	1357	AGC	82;83;83	A;G;C	73;74;74	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1326	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3699	82.4	1	SNP	p	S91F	1	.	.	271	273	TTC	877	879	TTC	84;84;84	T;T;C	67;65;68	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1326	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3699	82.4	1	SNP	p	G95N	0	.	.	283	285	GGC	889	891	GGC	89;91;91	G;G;C	72;75;74	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1326	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3699	82.4	1	SNP	p	D95G	1	.	.	283	285	GGC	889	891	GGC	89;91;91	G;G;C	72;75;74	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	27	404	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1871	50.7	1	SNP	p	G45D	1	.	.	133	135	GAC	825	827	GAC	96;96;96	G;A,G;C	83;77,1;82	mtrR.WHO_M_01390:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	296	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c17.ctg.1	1510	43.7	0	.	n	.	0	A197.	DEL	197	197	A	821	821	A	101	A	84	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1156	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3303	79.2	1	SNP	p	D86N	1	D86N	NONSYN	256	258	GAC	786	788	AAC	82;82;81	A,C;A,C;C,A	54,1;62,1;73,1	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1156	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3303	79.2	1	SNP	p	S87W	0	.	.	259	261	AGT	789	791	AGT	81;81;83	A,G,C;G,A;T,G	66,1,1;66,1;67,5	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1156	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3303	79.2	1	SNP	p	S87I	0	.	.	259	261	AGT	789	791	AGT	81;81;83	A,G,C;G,A;T,G	66,1,1;66,1;67,5	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1156	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3303	79.2	1	SNP	p	S87R	0	.	.	259	261	AGT	789	791	AGT	81;81;83	A,G,C;G,A;T,G	66,1,1;66,1;67,5	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1156	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3303	79.2	1	SNP	p	S88P	0	.	.	262	264	TCC	792	794	TCC	83;83;82	T,G;C,T;C	64,1;68,4;71	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	283	1222	parE	1986	1986	100.0	parE.l15.c17.ctg.1	3257	86.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1390	1392	CCG	101;101;100	C,G;C;G	90,1;85;82	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.13.001	penA.13.001	1	1	27	892	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2971	63.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1555	1557	GCA	111;114;114	G;C;A,C	93;94;91,1	penA.13.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.13.001	penA.13.001	1	1	27	892	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2971	63.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1558	1560	ATC	114;114;113	A;T;C	96;99;98	penA.13.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.13.001	penA.13.001	1	1	27	892	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2971	63.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1570	1572	GTG	113;113;114	G;T;G	96;94;95	penA.13.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.13.001	penA.13.001	1	1	27	892	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2971	63.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1570	1572	GTG	113;113;114	G;T;G	96;94;95	penA.13.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.13.001	penA.13.001	1	1	27	892	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2971	63.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2074	2076	ACC	85;86;85	A;C;C	57;67;71	penA.13.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.13.001	penA.13.001	1	1	27	892	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2971	63.9	1	SNP	p	V502P	0	.	.	1504	1506	GTG	2128	2130	GTG	56;55;55	G,T;T,G;G	45,1;42,1;43	penA.13.001:1:1:V502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.13.001	penA.13.001	1	1	27	892	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2971	63.9	1	SNP	p	A502V	1	.	.	1504	1506	GTG	2128	2130	GTG	56;55;55	G,T;T,G;G	45,1;42,1;43	penA.13.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.13.001	penA.13.001	1	1	27	892	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2971	63.9	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2251	2253	GGC	63;64;65	G;G;C,T	54;55;55,1	penA.13.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.13.001	penA.13.001	1	1	27	892	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2971	63.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2260	2262	GGC	59;59;58	G;G;C	51;49;37	penA.13.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.13.001	penA.13.001	1	1	27	892	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2971	63.9	1	SNP	p	P552S	1	.	.	1654	1656	TCG	2278	2280	TCG	62;63;63	T,G;C,T;G	42,6;50,1;52	penA.13.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	924	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3768	51.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1939	1941	CCG	92;93;95	C,G,T;C;G,C	71,2,1;75;67,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	514	porA	1146	1146	99.74	porA.l6.c4.ctg.1	2211	53.6	0	.	p	.	0	A17T	NONSYN	49	51	GCA	542	544	ACA	45;45;43	A;C;A	39;36;36	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	514	porA	1146	1146	99.74	porA.l6.c4.ctg.1	2211	53.6	0	.	p	.	0	S22G	NONSYN	64	66	AGC	557	559	GGC	45;45;45	G;G;C	39;38;38	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	514	porA	1146	1146	99.74	porA.l6.c4.ctg.1	2211	53.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	739	739	C	48	C	39	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	438	porB1b	1041	1041	98.08	porB1b.l6.c4.ctg.1	2365	42.9	0	.	p	.	0	E48G	NONSYN	142	144	GAA	830	832	GGA	60;59;59	G,A;G;A	50,1;50;50	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	438	porB1b	1041	1041	98.08	porB1b.l6.c4.ctg.1	2365	42.9	0	.	p	.	0	T87A	NONSYN	259	261	ACT	947	949	GCT	67;67;67	G,A;C;T,C	59,1;58;57,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	438	porB1b	1041	1041	98.08	porB1b.l6.c4.ctg.1	2365	42.9	0	.	p	.	0	T89S	NONSYN	265	267	ACC	953	955	AGC	67;67;67	A,C;G;C	52,1;54;57	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	438	porB1b	1041	1041	98.08	porB1b.l6.c4.ctg.1	2365	42.9	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	1115	1117	CAA	66;68;68	C,A;A;A	55,2;59;58	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	438	porB1b	1041	1041	98.08	porB1b.l6.c4.ctg.1	2365	42.9	0	.	p	.	0	V151A	NONSYN	451	453	GTA	1139	1141	GCA	58;58;58	G;C,T;A	51;47,1;49	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	438	porB1b	1041	1041	98.08	porB1b.l6.c4.ctg.1	2365	42.9	0	.	p	.	0	R187Q	NONSYN	559	561	CGA	1247	1249	CAA	55;55;55	C;A;A	47;46;47	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	438	porB1b	1041	1041	98.08	porB1b.l6.c4.ctg.1	2365	42.9	0	.	p	.	0	N189S	NONSYN	565	567	AAC	1253	1255	AGC	54;54;55	A;G;C	46;46;47	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	438	porB1b	1041	1041	98.08	porB1b.l6.c4.ctg.1	2365	42.9	0	.	p	.	0	Y212fs	FSHIFT	634	634	T	1322	1322	T	50	T	40	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	438	porB1b	1041	1041	98.08	porB1b.l6.c4.ctg.1	2365	42.9	1	SNP	p	G120K	1	.	.	358	360	AAG	1046	1048	AAG	60;60;60	A;A;G	50;51;50	porB1b.WHO_M_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	438	porB1b	1041	1041	98.08	porB1b.l6.c4.ctg.1	2365	42.9	1	SNP	p	A121D	1	.	.	361	363	GAC	1049	1051	GAC	62;62;62	G;A;C	51;51;50	porB1b.WHO_M_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	438	porB1b	1041	1041	98.08	porB1b.l6.c4.ctg.1	2365	42.9	1	SNP	p	D121N	0	.	.	361	363	GAC	1049	1051	GAC	62;62;62	G;A;C	51;51;50	porB1b.WHO_M_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	1324	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5421	53.9	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2238	2240	AAT	62;60;60	A,C;A;T	49,1;49;49	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	156	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1402	26.7	1	SNP	p	V57M	1	.	.	169	171	ATG	700	702	ATG	57;57;57	A;T;G	51;51;51	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
